The global antiviral therapy market is expanding as the rising prevalence of viral infections, technological advancements in antiviral drug development, increasing healthcare expenditure, and growing awareness and improved access to antiviral therapies accelerate market growth. The market was valued at approximately USD 42.77 billion in 2023, about USD 45.47 billion in 2024, and is projected to...